Cellectis
  • About
    Our mission
    Governance
    Partners
  • Science
    Our Genome Engineering Platform
    TALEN® Technology
    In-House Manufacturing
  • Pipeline
    Product Candidates
  • Investors
    IR Overview
    News
    • Press releases
    • Events and Webcasts
    Presentations
    • Corporate presentations
    • Scientific presentations
    • Scientific publications
    Corporate Governance
    • Board of Directors
    • Executive Committee
    • External Auditors
    • Governance Documents
    • General meetings
    Financial Information
    • SEC filings
    • Financial statements
    • Voting Rights & Share Capital
    • Stock information
    Shareholders Services
    • IR Inquiries
    • IR FAQ
  • Careers
    Our culture
    Job opportunities
  • Contact us
LinkedinX FR
› Events
  • About
    • Our mission
    • Governance
    • Partners
  • Science
    • Our Genome Engineering Platform
    • TALEN® Technology
    • In-House Manufacturing
  • Pipeline
    • Product Candidates
  • Investors
    • IR Overview
    • News
      • Press releases
      • Events and Webcasts
    • Presentations
      • Corporate presentations
      • Scientific presentations
      • Scientific publications
    • Corporate Governance
      • Board of Directors
      • Executive Committee
      • External Auditors
      • Governance Documents
      • General meetings
    • Financial Information
      • SEC filings
      • Financial statements
      • Voting Rights & Share Capital
      • Stock information
    • Shareholders Services
      • IR Inquiries
      • IR FAQ
  • Careers
    • Our culture
    • Job opportunities
  • Contact us
FR
LinkedinX

Events

All 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
December 22, 2023

Cellectis’ Shareholders Meeting to be Held on December 22, 2023

Read more
December 9, 2023 - December 13, 2023

American Society of Hematology (ASH) 65th Annual Meeting

Read more
December 5, 2023 - December 7, 2023

The JMP Securities Hematology and Oncology Summit

Read more
December 4, 2023 - December 7, 2023

5th Annual Cell Therapy Analytical Development Summit

Read more
November 28, 2023 - November 30, 2023

Evercore ISI 6th Annual Evercore ISI HealthCONx Conference

Read more
November 14, 2023 - November 16, 2023

Jefferies London Healthcare Conference

Read more
November 7, 2023 - November 8, 2023

Cellectis Third Quarter 2023 Earnings Conference Call

Read more
November 6, 2023 - November 9, 2023

Bio-Europe 2023

Read more
November 4, 2023 - November 5, 2023

Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting

Read more
October 24, 2023 - October 28, 2023

European Society of Gene and Cell Therapy (ESGCT) 2023 Annual Conference

Read more

Posts pagination

1 2 3 4 NEXT →

Press contacts

For more information on any story, or for press enquiries, get in touch with our communication team

CONTACT US
cellectis

Clinical-stage biotech · Dual-listed on Nasdaq (CLLS) and Euronext Growth (ALCLS).
Paris · New York · Raleigh.

  • ABOUT
    • Our mission
    • Governance
    • Partners
  • SCIENCE
    • Our Genome Engineering Platform
    • TALEN® Technology
    • In-House Manufacturing
  • PIPELINE
    • Product Candidates
  • INVESTORS
    • Events
    • Corporate presentations
    • Scientific presentations
    • Scientific publications
    • Governance Documents
    • ESG report
    • Shareholders Meetings
    • SEC filings
    • Financial statements
    • Voting Rights & Share Capital
    • Stock information
    • PDMR Notifications
    • IR Inquiries
    • IR FAQ
  • Careers
    • Our culture
    • Job opportunities
© 2026 Cellectis — All rights reserved
  • Legal notice
  • Community Guidelines